Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CM529D1 in Advanced Solid Tumors
NCT07893171Phase 2Not yet recruiting
- Sponsor
- Keymed Biosciences
- Start
- Nov 2026
- Primary completion
- Dec 2029
- Countries
- 1
01
Overview
A Phase 2 trial of CM529D1 in solid tumor, sponsored by Keymed Biosciences. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
CM529D1
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT07893171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07893171.